Keywords: Prostate neoplasms; Castration-resistant; Biomarkers; Receptors; Androgen; Genetic; Abiraterone acetate; MDV 3100; Docetaxel; Cabazitaxel
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: prostatic neoplasms; prostatic neoplasms; castration-resistant; dutasteride; MDV 3100; antineoplastic combined chemotherapy protocolsADT, androgen deprivation therapy; AR, androgen receptor; BPH, benign prostatic hyperplasia; CI, combination index; CRPC,
Long-Term Antitumor Activity and Safety of Enzalutamide Monotherapy in Hormone Naïve Prostate Cancer: 3-Year Open Label Followup Results
Keywords: prostatic neoplasms; prostate-specific antigen; MDV 3100; bone density; drug related side effects and adverse reactions; ADT; androgen deprivation therapy; AE; adverse event; bALP; bone alkaline phosphate; BMD; bone mineral density; CR; complete response;
Efficacy and Safety of Enzalutamide vs Bicalutamide in Younger and Older Patients with Metastatic Castration Resistant Prostate Cancer in the TERRAIN Trial
Keywords: prostatic neoplasms; neoplasm metastasis; castration; MDV 3100; drug-related side effects and adverse reactions; AE; adverse event; AFFIRM; Study Evaluating the Efficacy and Safety of the Investigational Drug MDV3100; FACT-P; Functional Assessment of Canc
Clinical Outcomes of Chemotherapy Naïve Men with Metastatic Castration Resistant Prostate Cancer and Low Baseline Prostate Specific Antigen Treated with Enzalutamide vs Placebo
Keywords: prostatic neoplasms; castration-resistant; receptors; androgen; prostate-specific antigen; MDV 3100; treatment outcome; ADT; androgen deprivation therapy; AR; androgen receptor; mCRPC; metastatic castration resistant prostate cancer; OS; overall survival;